×
Home
Current Archive Submission Guidelines
News Contact
Review article

Anxiety disorders: Where do we stand now? Current medicamentous treatment knowledge and future perspectives

By
Nikola Stojanović Orcid logo ,
Nikola Stojanović
Gordana Nikolić ,
Gordana Nikolić
Milica Todorovska ,
Milica Todorovska
Pavle Ranđelović Orcid logo ,
Pavle Ranđelović
Nenad Stojiljković ,
Nenad Stojiljković
Niko Radulović Orcid logo
Niko Radulović

Abstract

The frequency of anxiety disorders has been significantly increasing during the last few decades, especially within the younger population. This review article inclines to explain the differences between fear and anxiety, types of disorders that might mimic anxiety or induce it, and the involvement of different neural circuits in the processing of anxiety information. A significant portion of the paper is dedicated to the current pharmacological treatment of these disorders which represents a basis for the treatment of anxiety. Also, we addressed a potential application of herbal remedies for the treatment of different anxiety spectrum disorders.

References

1.
Baldwin D. Room for Improvement in the Pharmacological Treatment of Anxiety Disorders. Current Pharmaceutical Design. 2008;14(33):3482–91.
2.
Bystritsky A, Khalsa SS, Cameron ME, Schiffman J. Current diagnosis and treatment of anxiety disorders. P T. 2013;38:30–57.
3.
McCall JG, Siuda ER, Bhatti DL, Lawson LA, McElligott ZA, Stuber GD, et al. Locus coeruleus to basolateral amygdala noradrenergic projections promote anxiety-like behavior. eLife. 6.
4.
Ahissar E, Oram T. Thalamic Relay or Cortico-Thalamic Processing? Old Question, New Answers. Cerebral Cortex. 2015;25(4):845–8.
5.
Lee S, Shin HS. The role of mediodorsal thalamic nucleus in fear extinction. Journal of Analytical Science and Technology. 2016;7(1).
6.
Garcia-Rill E, Kezunovic N, Hyde J, Simon C, Beck P, Urbano FJ. Coherence and frequency in the reticular activating system (RAS). Sleep Medicine Reviews. 2013;17(3):227–38.
7.
Anxiety Disorders. 2010.
8.
Baldwin DS, In BE. The Wiley Handbook of Anxiety Disorders. 2014.
9.
Thibaut F. Anxiety disorders: a review of current literature. Dialogues in Clinical Neuroscience. 2017;19(2):87–8.
10.
Liberzon I, Duval E, Javanbakht A. Neural circuits in anxiety and stress disorders: a focused review. Therapeutics and Clinical Risk Management. :115.
11.
Bandelow B, Michaelis S, Wedekind D. Treatment of anxiety disorders. Dialogues in Clinical Neuroscience. 2017;19(2):93–107.
12.
Muscatello MR, Spina E, Bandelow B, Baldwin DS. Clinically relevant drug interactions in anxiety disorders. Human Psychopharmacology: Clinical and Experimental. 2012;27(3):239–53.
13.
Hanson C, Modiba W. Overview and management of anxiety disorders. S Afr Pharm J. 2017;84:43–50.
14.
Nutt DJ. Overview of Diagnosis and Drug Treatments of Anxiety Disorders. CNS Spectrums. 2005;10(1):49–56.
15.
Katzung B, Masters SB, Trevor AJ. Basic and Clinical Pharmacology. 2012.
16.
Goddard AW, Brouette T, Almai A, Jetty P, Woods SW, Charney D. Early Coadministration of Clonazepam With Sertraline for Panic Disorder. Archives of General Psychiatry. 2001;58(7):681.
17.
Sarris J. Herbal medicines in the treatment of psychiatric disorders: 10‐year updated review. Phytotherapy Research. 2018;32(7):1147–62.
18.
Yeung KS, Hernandez M, Mao JJ, Haviland I, Gubili J. Herbal medicine for depression and anxiety:<scp>A</scp>systematic review with assessment of potential psycho‐oncologic relevance. Phytotherapy Research. 2018;32(5):865–91.
19.
Blaustein JD. Handbook of Neurochemistry and Molecular Neurobiology: Behavioral Neurochemistry, Neuroendocrinology and Molecular Neurobiology. 2006.
20.
Craig KJ, Brown KJ, Baum A. Environmental factors in the etiology of anxiety. In: Psychopharmacology: the Fourth Generation of Progress. 1995. p. 1325–39.
21.
Shin LM, Liberzon I. The Neurocircuitry of Fear, Stress, and Anxiety Disorders. Neuropsychopharmacology. 2010;35(1):169–91.
22.
straha SVB, strahu, fobiji. Mladost Biro. 2005;
23.
Morris LW, Davis MA, Hutchings CH. Cognitive and emotional components of anxiety: Literature review and a revised worry–emotionality scale. Journal of Educational Psychology. 73(4):541–55.
24.
Nešić M. Pshichoneuroendocrino-immunology of stress, Faculty of Medicine, Niš, Serbia 2005.
25.
Barlow DH. Unraveling the mysteries of anxiety and its disorders from the perspective of emotion theory. American Psychologist. 55(11):1247–63.
26.
Barlow DH. Anxiety and its disorders: The nature and treatment of anxiety and panic. 1988.
27.
Gelenberg AJ. Psychiatric and Somatic Markers of Anxiety. The Primary Care Companion For CNS Disorders. 2(2).
28.
Steimer T. The biology of fear- and anxiety-related behaviors. Dialogues in Clinical Neuroscience. 2002;4(3):231–49.
29.
Mayer EA. Gut feelings: the emerging biology of gut–brain communication. Nature Reviews Neuroscience. 2011;12(8):453–66.
30.
Emond M, Schwartz GJ, Moran TH. Meal-related stimuli differentially induce c-Fos activation in the nucleus of the solitary tract. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2001;280(5):R1315–21.
31.
Stern T, Fricchione G, Rosenbaum J. Massachusetts General Hospital Handbook of General Hospital Psychiatry. 2010.
32.
Remes O, Brayne C, van der Linde R, Lafortune L. A systematic review of reviews on the prevalence of anxiety disorders in adult populations. Brain and Behavior. 2016;6(7).
33.
Bandelow B, Michaelis S. Epidemiology of anxiety disorders in the 21st century. Dialogues in Clinical Neuroscience. 2015;17(3):327–35.
34.
Stojanović NM, Samardžić L, Randjelović PJ, Radulović NS. Prevalence of self-medication practice with herbal products among non-psychotic psychiatric patients from southeastern Serbia: A cross-sectional study. Saudi Pharmaceutical Journal. 2017;25(6):884–90.
35.
Bourin M. Animal models for screening anxiolytic-like drugs: a perspective. Dialogues in Clinical Neuroscience. 2015;17(3):295–303.

Citation

Article metrics

Google scholar: See link

Citations

Crossref Logo

7

Crossref Logo

Darko Laketić, Nikola M. Stojanović, Isidora Laketić, Milorad Pavlović, Bojan Milosević, Ana Starčević, Slobodan Kapor

(2025)

Insular Cortex—Biology and Its Role in Psychiatric Disorders: A Narrative Review

Brain Sciences, 15(8)

10.3390/brainsci15080793

Crossref Logo

Nikola Stojanović, Pavle Ranđelović, Gordana Nikolić, Nenad Stojiljković, Sonja Ilić, Bogdan Stoiljković, Niko Radulović

(2020)

Reliability and validity of the Spielberger&#039;s State-Trait Anxiety Inventory (STAI) in Serbian university student and psychiatric non-psychotic outpatient populations

AFMN Biomedicine, 37(2)

10.5937/afmnai37-25011

Crossref Logo

Nikola M. Stojanović, Pavle J. Randjelović, Dragana Pavlović, Nenad I. Stojiljković, Ivan Jovanović, Dušan Sokolović, Niko S. Radulović, Mateusz Maciejczyk

(2021)

An Impact of Psychological Stress on the Interplay between Salivary Oxidative Stress and the Classic Psychological Stress‐Related Parameters

Oxidative Medicine and Cellular Longevity, 2021(1)

10.1155/2021/6635310

Crossref Logo

Pavle J. Randjelović, Niko S. Radulović, Nikola M. Stojanović, Vidoslav S. Dekić, Biljana R. Dekić, Nenad I. Stojiljković, Sonja M. Ilić

(2020)

Anxiolytic‐Like Action of Selected 4‐(Alkylamino)‐3‐nitrocoumarin Derivatives in BALB/c Mice

Chemistry & Biodiversity, 17(6)

10.1002/cbdv.202000206

Crossref Logo

Anastasiia Shkodina, Tymur Iengalychev, Kateryna Tarianyk, Dmytro Boiko, Nataliia Lytvynenko, Andrii Skrypnikov

(2022)

Relationship between sleep disorders and neuropsychiatric symptoms in Parkinson&#039;s disease: A narrative review

AFMN Biomedicine, 39(3)

10.5937/afmnai39-33652

Crossref Logo

Nikola M. Stojanović, Marko Z. Mladenović, Aleksandra Maslovarić, Nenad I. Stojiljković, Pavle J. Randjelović, Niko S. Radulović

(2022)

Lemon balm (Melissa officinalis L.) essential oil and citronellal modulate anxiety-related symptoms – In vitro and in vivo studies

Journal of Ethnopharmacology, 284()

10.1016/j.jep.2021.114788

Crossref Logo

Dmytro Boiko, Oksana Mats, Liliia Zhyvotovska, Larysa Herasymenko, Andrii Skrypnikov

(2023)

Psychoeducational training for healthcare workers psychoeducational training for reducing the impact of COVID-19 pandemic on healthcare workers

AFMN Biomedicine, 40(4)

10.5937/afmnai40-42652

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.